Fate Therapeutics Inc (NASDAQ:FATE)

6.07
Delayed Data
As of Jun 29
 -0.23 / -3.65%
Today’s Change
3.50
Today|||52-Week Range
8.78
+20.68%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close6.30
Today’s open5.29
Day’s range5.22 - 6.20
Volume334,068
Average volume (3 months)147,055
Market cap$167.8M
Dividend yield--
Data as of 4:00pm ET, 06/29/2015

Growth & Valuation

Earnings growth (last year)+64.12%
Earnings growth (this year)-12.01%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.57

Competitors

 Today’s
change
Today’s
% change
ASTAsterias Biotherapeu...-0.57-13.35%
PSTIPluristem Therapeuti...-0.07-2.73%
CURNeuralstem Inc-0.24-11.88%
CRMDCorMedix Inc-0.81-16.67%
Data as of 4:05pm ET, 06/29/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$0.00
Annual profit (last year)-$25.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christian Weyer
Chief Financial &
Operating Officer
J. Scott Wolchko
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers